My Account

Username :

Password :


Create New Account
Forgot Password?
     

Keyword Search


     

Speakers


Browse all DCP Speakers

     

Shopping Cart

You have (0) items
in your cart.



     

Contact Us


EMAIL US

     

Return to Digital Conference Providers Inc. Events Library Menu

Herb Rubenstein
[ Close ]
Herb Rubenstein Biography President, Sustainable Business Group Affiliation

Sustainable Business Group

Website

Herb Rubenstein Herb RubensteinPresident, Sustainable Business G  (more ...)


Michael H. Rubin
[ Close ]
Michael H. Rubin Biography Michael H. Rubin is one of the managing partners of the multi-state firm of McGlinchey Stafford and has an active finance, commercial litigation, and appellate practice. He has presented over 225 papers on ethics, professionalism, real estate and other topics throughout the United States, England, and Canada; his writings on ethics and professionalism have been utilized in law school courses around the country. Mr. Rubin is the author, co-author, and contributing writer of 11 books and more than 30 law review articles and periodicals. He has served as president of the American College of Real Estate Lawyers, the U.S. Fifth Circuit Bar Association, the Louisiana State Bar Association, and the Southern Conference of Bar Presidents. He is a member of the American Law Institute, the American College of Commercial Finance Lawyers, and the American College of Mortgage Attorneys. For more than three decades he has taught courses in real estate finance as a adjunct professor at Tulane Law School, L.S.U. Law School, and other law schools. He currently serves as Chair of the Real Property’s Ethics Committee and resides in Baton Rouge, Louisiana. Affiliation

McGlinchey Stafford PLLC

Website

Michael H. Rubin Michael H. RubinMichael H. Rubin is one of the managing partners of the multi-state firm of McGlinchey Stafford has an active finance, commercial litigation,   (more ...)


Irwin N. Rubin
[ Close ]
Irwin N. Rubin Biography Irwin Rubin, counsel to Danziger & Markhoff LLP, practices in the areas of tax and employee benefit law. He works with closely held businesses and their principals to structure retirement and pension plans, general tax planning, and estate planning. He assists clients to design retirement plans to attain the greatest tax advantages permissible under the law, ensure compliance with applicable IRS and ERISA requirements on an ongoing basis, and restructure and amend plans as circumstances warrant. He has extensive experience in such areas as prohibited transaction exemptions, correction of plan audit problems; obtaining Section 501 (c) (3) tax exempt status, and negotiation on behalf of clients with the IRS, Department of Labor and the Pension Benefit Guaranty Corporation. A graduate of Franklin and Marshall College (BA 1971) and Duke University Law School (1974), Irwin also earned an LLM in Taxation from New York University (1975). Affiliation

Danziger & Markhoff LLP, White Plains, NY

Website

Irwin N. Rubin Irwin N. RubinIrwin Rubin, counsel to Danziger & Markhoff LLP, practices in areas of tax and employee benefit law. He works with closely held businesses and  (more ...)


M. Rubin
[ Close ]
M. Rubin Biography Affiliation

Website

M. Rubin M. Rubin  (more ...)


Lee Rubin, PhD
[ Close ]
Lee Rubin, PhD Biography Lee Rubin, PhD, Harvard University Dr. Rubin received his Ph.D. in Neuroscience from The Rockefeller University and completed postdoctoral fellowships in Pharmacology from Harvard Medical School and in Neurobiology from Stanford University School of Medicine. He was then an Assistant and Associate Professor at Rockefeller University. Subsequently, he joined Athena Neurosciences (now Elan Pharmaceuticals) as head of their blood-brain barrier (BBB) and multiple sclerosis groups, ultimately initiating a project to discover an antibody that blocks lymphocyte trafficking across the BBB. This work successfully identified an anti-integrin antibody, now known as Tysabri, which has been approved for treatment of multiple sclerosis and more recently, for Crohn’s disease. After leaving Athena, he became Professor of Anatomy and Developmental Biology at University College London and Director of the Eisai London Laboratory of Neurodegenerative Disease. This institute was sponsored by Eisai Co., a major Japanese pharmaceutical company, and focused on discovering novel therapeutic approaches for diseases of the nervous system. In 1998, he returned to Boston as Chief Scientific Officer of Ontogeny, Inc (now Curis, Inc) a biotechnology company in Cambridge, MA, founded by Dr. Douglas Melton, a well-known stem cell and developmental biologist. Dr. Rubin's work there centered on the hedgehog (Hh) pathway and its involvement in cancer and neurodegenerative disease. Potent small molecule Hh antagonists were identified and partnered with Genentech for clinical development. Two INDs were submitted, and one phase II study is currently underway for an orally available Hh antagonist used to treat solid tumors. Small molecule Hh agonists were also identified and partnered with Wyeth Pharmaceuticals for development, with stroke as the initial lead indication. In July 2006, Dr. Rubin moved to the Harvard University Stem Cell Institute as Director of Translational Medicine and is a member of the new Department of Stem Cell and Regenerative Biology. Much of his effort there is devoted to identifying therapeutics for orphan neural disorders such as Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis, Huntington’s Disease and multiple sclerosis using new kinds of stem cell-based screens. He also directs a group that carries out a broad set of stem cell differentiation assays with numerous other members of the Harvard Stem Cell Institute. Affiliation

Website

Lee Rubin, PhD Lee Rubin, PhDLee Rubin, PhD, Harvard University Dr. Rubin received his Ph.D. in Neuroscience from The Rockefeller University and completed postdoctoral fe  (more ...)


Lee  Rubin, PhD
[ Close ]
Lee Rubin, PhD Biography Dr. Rubin received his Ph.D. in Neuroscience from The Rockefeller University and completed postdoctoral fellowships in Pharmacology from Harvard Medical School and in Neurobiology from Stanford University School of Medicine. He was then an Assistant and Associate Professor at Rockefeller University. Subsequently, he joined Athena Neurosciences (now Elan Pharmaceuticals) as head of their blood-brain barrier (BBB) and multiple sclerosis groups, ultimately initiating a project to discover an antibody that blocks lymphocyte trafficking across the BBB. This work successfully identified an anti-integrin antibody, now known as Tysabri, which has been approved for treatment of multiple sclerosis and more recently, for Crohn’s disease. After leaving Athena, he became Professor of Anatomy and Developmental Biology at University College London and Director of the Eisai London Laboratory of Neurodegenerative Disease. This institute was sponsored by Eisai Co., a major Japanese pharmaceutical company, and focused on discovering novel therapeutic approaches for diseases of the nervous system. In 1998, he returned to Boston as Chief Scientific Officer of Ontogeny, Inc (now Curis, Inc) a biotechnology company in Cambridge, MA, founded by Dr. Douglas Melton, a well-known stem cell and developmental biologist. Dr. Rubin's work there centered on the hedgehog (Hh) pathway and its involvement in cancer and neurodegenerative disease. Potent small molecule Hh antagonists were identified and partnered with Genentech for clinical development. Two INDs were submitted, and one phase II study is currently underway for an orally available Hh antagonist used to treat solid tumors. Small molecule Hh agonists were also identified and partnered with Wyeth Pharmaceuticals for development, with stroke as the initial lead indication. In July 2006, Dr. Rubin moved to the Harvard University Stem Cell Institute as Director of Translational Medicine and is a member of the new Department of Stem Cell and Regenerative Biology. Much of his effort there is devoted to identifying therapeutics for orphan neural disorders such as Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis, Huntington’s Disease and multiple sclerosis using new kinds of stem cell-based screens. He also directs a group that carries out a broad set of stem cell differentiation assays with numerous other members of the Harvard Stem Cell Institute. Affiliation

Harvard University

Website

Lee  Rubin, PhD Lee Rubin, PhDDr. Rubin received his Ph.D. in Neuroscience from The Rockefeller University and completed postdoctoral fellowships in Pharmacology from Harvard M  (more ...)


Wendy S.  Rubinstein
[ Close ]
Wendy S. Rubinstein Biography MD, PhD, FACMG, FACP, NorthShore University Health System Affiliation

Website

Wendy S.  Rubinstein Wendy S. RubinsteinMD, PhD, FACMG, FACP, NorthShore University Health Sy  (more ...)


Alexei Rudolf
[ Close ]
Alexei Rudolf Biography Past President of IFEC and Senior Account Supervisor at Edelman Affiliation

Edelman

Website

Alexei Rudolf Alexei RudolfPast President of IFEC and Senior Account Supervisor at Ede  (more ...)


Dorota E.  Rudomina, CT(ASCP)
[ Close ]
Dorota E. Rudomina, CT(ASCP) Biography Cytotechnologist, New York, NY Affiliation

Memorial Sloan-Kettering Cancer Center

Website

Dorota E.  Rudomina, CT(ASCP) Dorota E. Rudomina, CT(ASCP) Cytotechnologist, New York  (more ...)


Fred Rueggeberg, DDS, MS
[ Close ]
Fred Rueggeberg, DDS, MS Biography Professor and Section Director, Dental Materials, Department of Oral Rehabilitation, MCG School of Dentistry, Augusta, GA Affiliation

MCG School of Dentistry

Website

Fred Rueggeberg, DDS, MS Fred Rueggeberg, DDS, MSProfessor and Section Director, Dental Materials, Department of Oral Rehabilitation, MCG School of Dentistry, Augusta,   (more ...)



PREV10 -  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456  -  NEXT10
All Libraries

Contact Us : customersupport@dcproviders.com
Digital Conference Providers, Inc. - 100 S. Cass Ave. Ste 200 - Westmont, IL 60559
Phone (630) 963-8311 - Fax (630) 963-8312